Last reviewed · How we verify
Normal saline pyloric injection — Competitive Intelligence Brief
marketed
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Normal saline pyloric injection (Normal saline pyloric injection) — Albany Medical College. Normal saline injection into the pyloric muscle causes mechanical disruption and edema that temporarily obstructs gastric outlet flow, reducing symptoms of pyloric stenosis.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Normal saline pyloric injection TARGET | Normal saline pyloric injection | Albany Medical College | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Normal saline pyloric injection CI watch — RSS
- Normal saline pyloric injection CI watch — Atom
- Normal saline pyloric injection CI watch — JSON
- Normal saline pyloric injection alone — RSS
Cite this brief
Drug Landscape (2026). Normal saline pyloric injection — Competitive Intelligence Brief. https://druglandscape.com/ci/normal-saline-pyloric-injection. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing